Your browser doesn't support javascript.
loading
Polyclonal RB1 mutations and acquired resistance to CDK 4/6 inhibitors in patients with metastatic breast cancer.
Condorelli, R; Spring, L; O'Shaughnessy, J; Lacroix, L; Bailleux, C; Scott, V; Dubois, J; Nagy, R J; Lanman, R B; Iafrate, A J; Andre, F; Bardia, A.
Afiliação
  • Condorelli R; Institute Gustave Roussy, Paris, France.
  • Spring L; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA.
  • O'Shaughnessy J; Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, USA; U.S. Oncology, Dallas, USA.
  • Lacroix L; Institute Gustave Roussy, Paris, France.
  • Bailleux C; Institute Gustave Roussy, Paris, France.
  • Scott V; Institute Gustave Roussy, Paris, France.
  • Dubois J; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA.
  • Nagy RJ; Guardant Health, Inc., Redwood City, USA.
  • Lanman RB; Guardant Health, Inc., Redwood City, USA.
  • Iafrate AJ; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA.
  • Andre F; Institute Gustave Roussy, Paris, France.
  • Bardia A; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, USA. Electronic address: Bardia.aditya@mgh.harvard.edu.
Ann Oncol ; 29(3): 640-645, 2018 03 01.
Article em En | MEDLINE | ID: mdl-29236940
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article